5.92
price up icon1.72%   0.10
after-market 시간 외 거래: 5.92
loading

Meiragtx Holdings Plc 주식(MGTX)의 최신 뉴스

pulisher
Nov 20, 2024

Chardan Capital Reiterates Buy Rating for MeiraGTx (NASDAQ:MGTX) - Defense World

Nov 20, 2024
pulisher
Nov 18, 2024

Trend Tracker for (MGTX) - Stock Traders Daily

Nov 18, 2024
pulisher
Nov 15, 2024

Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

MeiraGTx Holdings Reports Significant Losses Amid Strategic Moves - TipRanks

Nov 15, 2024
pulisher
Nov 14, 2024

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 14, 2024
pulisher
Nov 13, 2024

MeiraGTx wins 3 Rare Pediatric designations and updates on AAV-AIPL1 - The Pharma Letter

Nov 13, 2024
pulisher
Nov 13, 2024

MeiraGTx Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

MeiraGTx Holdings PLC Q3 2024 Earnings: Revenue Soars to $10.9M, EPS Misses Estimates at -$0.55 - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

MeiraGTx Scores Triple FDA Designations, Reports Strong Parkinson's Data Despite Q3 Loss | MGTX Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 08, 2024

Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good - Benzinga

Nov 08, 2024
pulisher
Nov 08, 2024

(MGTX) Trading Signals - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 01, 2024

Dynamic range: the key to MeiraGTx’s quest to control genes with pills - BioCentury

Nov 01, 2024
pulisher
Oct 29, 2024

Duchenne Muscular Dystrophy Therapeutics Market Trends, Growth Insights, and Forecasts 2033 - WhaTech

Oct 29, 2024
pulisher
Oct 29, 2024

Gene Therapy Market Detailed Analysis and Forecast to 2031 - InsightAce Analytic

Oct 29, 2024
pulisher
Oct 28, 2024

Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity - BioWorld Online

Oct 28, 2024
pulisher
Oct 22, 2024

MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress - The Manila Times

Oct 22, 2024
pulisher
Oct 21, 2024

High Growth Tech Stocks to Watch in October 2024 - Simply Wall St

Oct 21, 2024
pulisher
Oct 19, 2024

MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains? - MSN

Oct 19, 2024
pulisher
Oct 18, 2024

(MGTX) Long Term Investment Analysis - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 17, 2024

Cell therapy weekly: US$225 million investment towards world-class research institute - RegMedNet

Oct 17, 2024
pulisher
Oct 16, 2024

MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study - Clinical Trials Arena

Oct 16, 2024
pulisher
Oct 16, 2024

MeiraGTx Holdings plc Inc. (MGTX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 16, 2024
pulisher
Oct 16, 2024

MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

Items Tagged with 'glutamic acid decarboxylase' - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Items Tagged with 'AAV-GAD' - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Meiragtx looks to a phase III in Parkinson’s - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints - AOL

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx: Positive PD Data Moves Needle Forward For Regulatory Meetings (NASDAQ:MGTX) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx (MGTX) Sees Stock Surge After Clinical Results News - Stocks Telegraph

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx stock gains on Parkinson’s drug data (NASDAQ:MGTX) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

Investors in MeiraGTx Holdings (NASDAQ:MGTX) from three years ago are still down 75%, even after 13% gain this past week - Simply Wall St

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx reports positive Parkinson's gene therapy trial results By Investing.com - Investing.com UK

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson's Disease - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease - StockTitan

Oct 15, 2024
pulisher
Oct 15, 2024

Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data - Yahoo Finance

Oct 15, 2024
pulisher
Oct 12, 2024

Piper Sandler maintains Overweight rating on MeiraGTx shares - Investing.com

Oct 12, 2024
pulisher
Oct 11, 2024

Piper Sandler maintains Overweight rating on MeiraGTx shares By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 09, 2024

MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference - The Manila Times

Oct 09, 2024
pulisher
Oct 07, 2024

MeiraGTx Holdings plc's (NASDAQ:MGTX) Profit Outlook - Yahoo Finance

Oct 07, 2024
pulisher
Oct 03, 2024

DT Midstream (NYSE:DTM) Price Target Increased to $85.00 by Analysts at Barclays - Defense World

Oct 03, 2024
pulisher
Sep 30, 2024

MeiraGTx's SWOT analysis: gene therapy firm's stock faces pivotal year By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 27, 2024

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? - Yahoo Finance

Sep 27, 2024
pulisher
Sep 25, 2024

Bank of New York Mellon Corp Sells 14,485 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Sep 25, 2024
pulisher
Sep 23, 2024

Beck Capital Management LLC Has $2.07 Million Stock Holdings in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Financial Metrics Check: Macrogenics Inc (MGNX)’s Ratios for Trailing Twelve Months - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Leonardo Increases Stake In GEM Elettronica To 65% With EUR 16 Mln Investment - XM

Sep 23, 2024
pulisher
Sep 23, 2024

MyCelx drops as revenue guidance pushed on order delay - Proactive Investors USA

Sep 23, 2024
pulisher
Sep 22, 2024

Sei Investments Co. Decreases Stock Position in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Argent Trust Co Purchases New Stake in Globus Medical, Inc. (NYSE:GMED) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

MGO Global regains compliance with Nasdaq equity rule - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Macrogenics Inc [MGNX] Records 200-Day SMA of $9.69 - Knox Daily

Sep 20, 2024
pulisher
Sep 20, 2024

MeiraGTx (NASDAQ:MGTX) and LadRx (OTCMKTS:CYTR) Financial Contrast - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

MGNX Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. (MGNX) Investors of Filing Deadline in Class Action Lawsuit - PR Newswire

Sep 19, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):